Longo R, Zeng Y C, Sagratella S
Laboratorio di Farmacologia, Istituto Superiore Di Sanità, Roma, Italy.
Neurosci Lett. 1995 Nov 10;200(1):21-4. doi: 10.1016/0304-3940(95)12064-b.
The effects of the adenosine receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), and of the adenosine agonists N6-cyclopentyladenosine (CPA), N6-(2-phenylisopropyl)adenosine (R-PIA), and 2-[p-(carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamidoadenosin e (CGS 21680) were investigated on the hyperexcitability induced in the CA1 area of rat hippocampal slices by hypoxia or the epileptogenic agent 4-aminopiridine. Slice perfusion with the mixed adenosine receptor agonist R-PIA (0.2 microM) significantly (P < 0.05) decreased: (i) the number of slices showing a transient CA1 epileptiform bursting during the hypoxic period; (ii) the duration of the hypoxia-induced epileptiform bursting. Conversely, slice perfusion with the selective A1 adenosine receptor antagonists DPCPX (0.2 microM) or with the selective A2 adenosine receptor agonist CGS 21680 significantly (P < 0.05) increased the number of slices showing a transient CA1 epileptiform bursting during the hypoxic period but did not affect the duration of the hypoxia-induced epileptiform bursting. Neither drug significantly affected the number of slices showing functional recovery after hypoxia. Slice perfusion with DPCPX (0.2 microM) also significantly increased (P < 0.05) the number of slices showing a persistent CA1 epileptiform bursting during the reoxygenation period, while the other drugs failed to affect it. Slice perfusion with the selective A1 adenosine receptor agonist CPA (2 microM) or R-PIA (5 microM) significantly (P < 0.05) decreased the duration of the CA1 epileptiform bursting induced by 100 microM 4-aminopyridine. CGS 21680 (5 microM) perfused together with CPA (2 microM) significantly (P < 0.05) counteracted the inhibitory effects of the A1 adenosine receptor agonist on 4-aminopyridine epileptiform bursting, while it failed by itself to directly affect the 4-aminopyridine epileptiform bursting duration. The results produce evidence for a selective opposite modulation by A1 and A2 adenosine agonists in the control of hippocampal hyperexcitability induced by hypoxia or 4-aminopyridine but not in the post-hypoxic functional recovery.
研究了腺苷受体拮抗剂1,3 - 二丙基 - 8 - 环戊基黄嘌呤(DPCPX)以及腺苷激动剂N6 - 环戊基腺苷(CPA)、N6 -(2 - 苯异丙基)腺苷(R - PIA)和2 - [对 -(羧乙基)苯乙氨基] - 5'- N - 乙基羧酰胺腺苷(CGS 21680)对缺氧或致癫痫剂4 - 氨基吡啶诱导的大鼠海马切片CA1区兴奋性过高的影响。用混合腺苷受体激动剂R - PIA(0.2微摩尔)灌注切片显著(P < 0.05)降低了:(i)在缺氧期间出现短暂CA1癫痫样爆发的切片数量;(ii)缺氧诱导的癫痫样爆发的持续时间。相反,用选择性A1腺苷受体拮抗剂DPCPX(0.2微摩尔)或选择性A2腺苷受体激动剂CGS 21680灌注切片显著(P < 0.05)增加了在缺氧期间出现短暂CA1癫痫样爆发的切片数量,但不影响缺氧诱导的癫痫样爆发的持续时间。两种药物均未显著影响缺氧后显示功能恢复的切片数量。用DPCPX(0.2微摩尔)灌注切片也显著(P < 0.05)增加了在复氧期间出现持续性CA1癫痫样爆发的切片数量,而其他药物未能影响这一情况。用选择性A1腺苷受体激动剂CPA(2微摩尔)或R - PIA(5微摩尔)灌注切片显著(P < 0.05)缩短了由100微摩尔4 - 氨基吡啶诱导的CA1癫痫样爆发的持续时间。与CPA(2微摩尔)一起灌注CGS 21680(5微摩尔)显著(P < 0.05)抵消了A1腺苷受体激动剂对4 - 氨基吡啶癫痫样爆发的抑制作用,而其本身未能直接影响4 - 氨基吡啶癫痫样爆发的持续时间。这些结果证明了A1和A2腺苷激动剂在控制缺氧或4 - 氨基吡啶诱导的海马兴奋性过高方面具有选择性的相反调节作用,但在缺氧后功能恢复方面并非如此。